Key statistics
On Monday, Hansa Biopharma AB (0RC7:LSE) closed at 40.88, -28.66% below its 52-week high of 57.30, set on Aug 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 41.02 |
---|---|
High | 40.88 |
Low | 40.88 |
Bid | 39.62 |
Offer | 41.64 |
Previous close | 41.29 |
Average volume | 1.38k |
---|---|
Shares outstanding | 67.81m |
Free float | 48.58m |
P/E (TTM) | -- |
Market cap | 2.78bn SEK |
EPS (TTM) | -14.59 SEK |
Data delayed at least 20 minutes, as of Sep 23 2024 16:21 BST.
More ▼
Press releases
- Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
- Hansa Biopharma Announces Departure of Chief Commercial Officer, Matthew Shaulis
- Hansa Biopharma Reports Second Quarter 2024 Financial Results and Business Update
- Hansa Biopharma to host Q2 2024 interim results conference call
- Hansa Biopharma: increase in number of shares and votes
More ▼